Adult solid neoplasm
Showing 1 - 25 of >10,000
Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)
Active, not recruiting
- Adult Solid Neoplasm
- Erlotinib Hydrochloride
- Irinotecan Hydrochloride
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 12, 2023
Adult Solid Tumor Trial in Chicago (Carboplatin, Laboratory Biomarker Analysis, Paclitaxel)
Active, not recruiting
- Adult Solid Neoplasm
- Carboplatin
- +4 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jan 25, 2023
Relapsed Solid Tumor, Refractory Cancer, Solid Tumor, Adult Trial (STI-3258)
Withdrawn
- Relapsed Solid Neoplasm
- +2 more
- STI-3258
- (no location specified)
Jan 24, 2023
Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)
Not yet recruiting
- Metastatic Breast Cancer
- +2 more
- Patritumab deruxtecan
- (no location specified)
May 9, 2023
Solid Tumor, Adult, Metastasis Trial in West Islip (Palliative and Survivorship Care Model)
Recruiting
- Solid Tumor, Adult
- Metastasis
- Palliative and Survivorship Care Model
-
West Islip, New YorkGood Samaritan University Hospital
Jul 7, 2023
Solid Tumor, Metastatic Solid Tumor, Solid Carcinoma Trial in New York, Seattle (AZD1390, Stereotactic Body Radiotherapy)
Not yet recruiting
- Solid Tumor
- +5 more
- AZD1390
- Stereotactic Body Radiotherapy
-
New York, New York
- +1 more
Jan 12, 2023
Adult Solid Tumor, Bladder Carcinoma, Colon Carcinoma Trial in Duarte (Laboratory Biomarker Analysis, Modified Vaccinia Virus
Active, not recruiting
- Adult Solid Neoplasm
- +16 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
COVID-19 Pandemic on Adolescent and Young Adult Cancer Patients
Recruiting
- COVID-19 Infection
- +2 more
- Quality-of-Life Assessment
- Survey Administration
-
Houston, TexasM D Anderson Cancer Center
Oct 20, 2022
Metastatic Malignant Solid Tumor, Metastatic NUT Carcinoma, Unresectable Malignant Solid Tumor Trial (Abemaciclib, BET
Suspended
- Metastatic Malignant Solid Neoplasm
- +3 more
- Abemaciclib
- +3 more
-
Boston, MassachusettsDana-Farber - Harvard Cancer Center LAO
Sep 17, 2022
Solid Tumors, Adult, Metastatic Cancer Trial in San Francisco (Gallium-68 labelled (68Ga-) FAP-2286, Positron Emission
Recruiting
- Solid Tumors, Adult
- Metastatic Cancer
- Gallium-68 labelled (68Ga-) FAP-2286
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 1, 2022
Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Scottsdale (Counseling, Discussion, Informational
Not yet recruiting
- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm
- Counseling
- +5 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 4, 2023
A Retro-/Prospective, Non-interventional, Cohort Study in Adult
Active, not recruiting
- Solid Tumor, Adult
- +2 more
-
Amiens, France
- +3 more
Jul 22, 2022
Solid Tumors, Adult, PIK3CA Mutation-Related Tumors, PIK3CA Mutation Trial in San Francisco (Alpelisib, Carboplatin,
Not yet recruiting
- Solid Tumors, Adult
- +7 more
- Alpelisib
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 21, 2022
Metastatic Cancer, Unspecified Adult Solid Tumor Trial in Los Angeles (PARP inhibitor BMN-673, temozolomide, irinotecan HCl)
Completed
- Metastatic Cancer
- Unspecified Adult Solid Tumor
- PARP inhibitor BMN-673
- +4 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Sep 22, 2022
Advanced Malignant Solid Tumor, Cholangiocarcinoma, Metastatic Malignant Solid Tumor Trial in Columbus (Infigratinib)
Recruiting
- Advanced Malignant Solid Neoplasm
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 15, 2022
Tumor Trial in Quebec (SAR444200, Cemiplimab)
Recruiting
- Neoplasm
- SAR444200
- Cemiplimab
-
Providence, Rhode Island
- +3 more
Oct 17, 2022
Solid Tumor, Adult, Metastatic Cancer Trial in Copenhagen (Atezolizumab, 6-mercaptopurine, 6-thioguanine)
Active, not recruiting
- Solid Tumor, Adult
- Metastatic Cancer
- Atezolizumab, 6-mercaptopurine, 6-thioguanine
-
Copenhagen, DenmarkUniversity Hospital of Copenhagen, Rigshospitalet
Apr 26, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (6 Minute Walk Functional Test, Behavioral
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- 6 Minute Walk Functional Test
- +3 more
-
Houston, Texas
- +1 more
Jan 6, 2023
Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)
Recruiting
- Urothelial Carcinoma
- +20 more
- IK-175
- IK-175 and nivolumab
-
Gilbert, Arizona
- +9 more
Feb 3, 2022
Refractory Cancer, Metastatic Cancer, Recurrent Cancer Trial in Santa Monica (SNK01, Avelumab, Pembrolizumab)
Active, not recruiting
- Refractory Cancer
- +6 more
- SNK01
- +2 more
-
Santa Monica, CaliforniaSarcoma Oncology Research Center
Sep 25, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Prediabetes Trial in Duarte (Exercise Intervention, Nicotinamide
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Exercise Intervention
- Nicotinamide Riboside
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 30, 2022